• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy.稳定联合抗逆转录病毒疗法治疗的 HIV 感染者的努力程度和神经心理学表现。
J Neurovirol. 2017 Oct;23(5):725-733. doi: 10.1007/s13365-017-0557-5. Epub 2017 Sep 11.
2
Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.高效抗逆转录病毒治疗时代队列中的运动功能与人类免疫缺陷病毒相关认知障碍
Arch Neurol. 2008 Aug;65(8):1096-101. doi: 10.1001/archneur.65.8.1096.
3
The HIV Dementia Scale: predictive power in mild dementia and HAART.HIV痴呆量表:在轻度痴呆和高效抗逆转录病毒治疗中的预测能力。
J Neurol Sci. 2007 Sep 15;260(1-2):11-5. doi: 10.1016/j.jns.2006.03.023. Epub 2007 May 4.
4
Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.脑脊液中α-干扰素水平与非卧床HIV感染者的神经认知障碍相关。
J Neurovirol. 2017 Feb;23(1):106-112. doi: 10.1007/s13365-016-0466-z. Epub 2016 Jul 11.
5
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.接受高效抗逆转录病毒治疗(HAART)的HIV感染患者神经心理功能的可变益处。
Neurology. 2006 May 9;66(9):1447-50. doi: 10.1212/01.wnl.0000210477.63851.d3.
6
Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.确定一种用于新型HIV相关神经认知障碍筛查程序的最佳损伤评级方法。
J Clin Exp Neuropsychol. 2017 Oct;39(8):753-767. doi: 10.1080/13803395.2016.1263282. Epub 2017 Jan 4.
7
The influence of effort on neuropsychological performance in children: is performance on the TOMM indicative of neuropsychological ability?努力对儿童神经心理表现的影响:对本顿视觉保持测验(TOMM)的表现是否表明神经心理能力?
Appl Neuropsychol Child. 2014;3(1):31-7. doi: 10.1080/21622965.2012.686339. Epub 2012 May 17.
8
Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).使用马拉维若(CCR5拮抗剂)强化治疗可使接受cART治疗的慢性HIV感染受试者中表达CD16的单核细胞数量减少,并与神经认知测试表现的改善相关:对HIV相关神经认知疾病(HAND)的意义。
J Neurovirol. 2014 Dec;20(6):571-82. doi: 10.1007/s13365-014-0279-x. Epub 2014 Sep 17.
9
Examining the Test Of Memory Malingering Trial 1 and Word Memory Test Immediate Recognition as screening tools for insufficient effort.将记忆伪装测验试验1和词语记忆测验即时识别作为努力不足的筛查工具进行检验。
Assessment. 2007 Sep;14(3):215-22. doi: 10.1177/1073191106297617.
10
The effect of literacy and culture on cognitive effort test performance: An examination of the Test of Memory Malingering in Colombia.读写能力和文化对认知努力测试表现的影响:对哥伦比亚记忆错觉测试的检验。
J Clin Exp Neuropsychol. 2019 Dec;41(10):1015-1023. doi: 10.1080/13803395.2019.1644294. Epub 2019 Jul 19.

引用本文的文献

1
Banking on variability: A conceptual replication of the association between cognitive dispersion and financial management.基于变异性:认知分散与财务管理之间关联的概念性复制
Clin Neuropsychol. 2025 Jun 23:1-20. doi: 10.1080/13854046.2025.2522249.
2
Use of different anticholinergic scales and their correlation with anticholinergic symptom burden in a cohort of people living with HIV.使用不同的抗胆碱能量表及其与 HIV 感染者抗胆碱能症状负担的相关性。
J Antimicrob Chemother. 2024 Jan 3;79(1):66-77. doi: 10.1093/jac/dkad348.
3
Plasma Aβ42/Aβ40 Ratios in Older People With Human Immunodeficiency Virus.老年人中人类免疫缺陷病毒感染者的血浆 Aβ42/Aβ40 比值。
Clin Infect Dis. 2023 May 24;76(10):1776-1783. doi: 10.1093/cid/ciad001.
4
Cognitive Phenotypes of HIV Defined Using a Novel Data-driven Approach.基于新型数据驱动方法定义的 HIV 认知表型。
J Neuroimmune Pharmacol. 2022 Dec;17(3-4):515-525. doi: 10.1007/s11481-021-10045-0. Epub 2022 Jan 4.
5
Comparison of [11C]-PBR28 Binding Between Persons Living With HIV and HIV-Uninfected Individuals.HIV 感染者与未感染者的[11C]-PBR28 结合比较。
J Acquir Immune Defic Syndr. 2020 Oct 1;85(2):244-251. doi: 10.1097/QAI.0000000000002435.
6
Deep Learning Analysis of Cerebral Blood Flow to Identify Cognitive Impairment and Frailty in Persons Living With HIV.深度学习分析脑血流以识别 HIV 感染者的认知障碍和虚弱。
J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):496-502. doi: 10.1097/QAI.0000000000002181.
7
Intraindividual variability in neurocognitive performance: No influence due to HIV status or self-reported effort.个体间神经认知表现的可变性:不受 HIV 状态或自我报告的努力程度的影响。
J Clin Exp Neuropsychol. 2018 Dec;40(10):1044-1049. doi: 10.1080/13803395.2018.1508554. Epub 2018 Aug 20.

本文引用的文献

1
Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders.自我报告的欠佳努力对艾滋病毒相关神经认知障碍患病率估计的预测因素及影响
J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):203-210. doi: 10.1097/QAI.0000000000001371.
2
Defining cognitive impairment in people-living-with-HIV: the POPPY study.定义HIV感染者的认知障碍:罂粟花研究
BMC Infect Dis. 2016 Oct 28;16(1):617. doi: 10.1186/s12879-016-1970-8.
3
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.人类免疫缺陷病毒相关神经认知障碍——发病机制与治疗前景
Nat Rev Neurol. 2016 Apr;12(4):234-48. doi: 10.1038/nrneurol.2016.27. Epub 2016 Mar 11.
4
Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study.多中心艾滋病队列研究中与HIV相关的神经认知障碍的患病率。
Neurology. 2016 Jan 26;86(4):334-40. doi: 10.1212/WNL.0000000000002277. Epub 2015 Dec 30.
5
Neuropathological sequelae of Human Immunodeficiency Virus and apathy: A review of neuropsychological and neuroimaging studies.人类免疫缺陷病毒和淡漠的神经病理学后遗症:神经心理学和神经影像学研究综述。
Neurosci Biobehav Rev. 2015 Aug;55:147-64. doi: 10.1016/j.neubiorev.2015.04.008. Epub 2015 May 2.
6
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.HIV联合抗逆转录病毒治疗时代的神经认知变化:纵向CHARTER研究
Clin Infect Dis. 2015 Feb 1;60(3):473-80. doi: 10.1093/cid/ciu862. Epub 2014 Oct 31.
7
Controversies in HIV-associated neurocognitive disorders.HIV 相关神经认知障碍的争议。
Lancet Neurol. 2014 Nov;13(11):1139-1151. doi: 10.1016/S1474-4422(14)70137-1.
8
HIV Associated Neurocognitive Disorders.人类免疫缺陷病毒相关神经认知障碍
Infect Dis Rep. 2013 Jun 6;5(Suppl 1):e8. doi: 10.4081/idr.2013.s1.e8.
9
HIV-associated neurocognitive disorder.HIV 相关性神经认知障碍。
Lancet Infect Dis. 2013 Nov;13(11):976-86. doi: 10.1016/S1473-3099(13)70269-X.
10
Cognitive impairment in multiple sclerosis.多发性硬化症中的认知障碍。
Curr Neurol Neurosci Rep. 2012 Oct;12(5):618-27. doi: 10.1007/s11910-012-0294-3.

稳定联合抗逆转录病毒疗法治疗的 HIV 感染者的努力程度和神经心理学表现。

Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy.

机构信息

Department of Psychological Sciences, University of Missouri- St. Louis, St. Louis, USA.

Missouri Institute of Mental Health, St. Louis, USA.

出版信息

J Neurovirol. 2017 Oct;23(5):725-733. doi: 10.1007/s13365-017-0557-5. Epub 2017 Sep 11.

DOI:10.1007/s13365-017-0557-5
PMID:28895090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5656505/
Abstract

The expression of cognitive symptoms associated with HIV varies over time and across individuals. This pattern may reflect transient contextual factors, including the degree of effort exerted by individuals undergoing cognitive testing. The present study examined whether effort corresponds to the expression of persistent HIV-related cognitive impairment among individuals receiving combination antiretroviral therapy (cART). HIV+ individuals (n = 111) averaged 48.2 (14.9) years of age and 13.0 (2.7) years of education and HIV- individuals (n = 92) averaged 34.9 (17.2) years of age and 13.5 (1.9) years of education. Participants completed a neuropsychological battery and a clinically validated measure of effort (Test of Memory Malingering, trial 1). Results revealed that the vast majority of HIV+ (85%) and HIV- (89%) individuals performed above published guidelines for adequate effort. Furthermore, the expression of cognitive impairment in HIV was not related to effort performance. The results were unchanged when examining HIV+ individuals with and without viral suppression. Finally, disability and disability-seeking status, and a proxy measure of apathy did not correspond to effort levels in HIV+ individuals. These findings suggest that variability in the expression of cognitive impairment in the cART era is unlikely to represent overt effort failures or other confounds unrelated to the disease. Persistent cognitive impairment in HIV likely represents historical and/or ongoing disease mechanisms despite otherwise successful treatment.

摘要

与 HIV 相关的认知症状的表现随时间和个体而异。这种模式可能反映了短暂的环境因素,包括个体在进行认知测试时所付出的努力程度。本研究旨在探讨在接受联合抗逆转录病毒治疗(cART)的个体中,努力是否与持续的 HIV 相关认知障碍的表现相对应。HIV+ 个体(n=111)的平均年龄为 48.2(14.9)岁,平均受教育年限为 13.0(2.7)年;HIV- 个体(n=92)的平均年龄为 34.9(17.2)岁,平均受教育年限为 13.5(1.9)年。参与者完成了神经心理学测试和一项临床验证的努力测量(记忆伪装测试,第 1 次试验)。结果显示,绝大多数 HIV+(85%)和 HIV-(89%)个体的表现都超过了发表的充分努力指南。此外,HIV 患者认知障碍的表现与努力表现无关。当检查有和没有病毒抑制的 HIV+个体时,结果保持不变。最后,残疾和寻求残疾状态以及冷漠的代理指标与 HIV+个体的努力水平无关。这些发现表明,在 cART 时代,认知障碍表现的变化不太可能代表明显的努力失败或与疾病无关的其他混淆因素。尽管治疗效果良好,但 HIV 患者持续的认知障碍可能代表了历史和/或持续的疾病机制。